Pages that link to "Q28278406"

The following pages link to Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy (Q28278406):

Displaying 23 items.

• AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011 (Q30318240) (← links)
• Vacuum-Sealing as a Treatment Option for Severe Anthracycline Extravasation in a Breast Cancer Patient (Q34096302) (← links)
• Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary (Q35201332) (← links)
• Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs (Q36230443) (← links)
• Anthracycline extravasation injuries: management with dexrazoxane (Q37230281) (← links)
• Management of anthracycline extravasation into the pleural space (Q37302166) (← links)
• All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway (Q37686126) (← links)
• Drugs and pharmaceuticals: management of intoxication and antidotes. (Q37722677) (← links)
• Dexrazoxane efficacy for anthracycline extravasation: use in UK clinical practice (Q38081464) (← links)
• Treatment of anthracycline extravasations using dexrazoxane (Q38129316) (← links)
• Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. (Q38133907) (← links)
• Dexrazoxane: a management option for anthracycline extravasations (Q38143321) (← links)
• Extravasation injuries: a review. (Q38176727) (← links)
• Dexrazoxane for cardioprotection in older adults with acute myeloid leukemia (Q38809957) (← links)
• Anthraquinones As Pharmacological Tools and Drugs (Q38816745) (← links)
• Cardioprotective effect of dexrazoxane in a rat model of myocardial infarction: Anti-apoptosis and promoting angiogenesis (Q53307613) (← links)
• Diethyl Blechnic, a Novel Natural Product Isolated from Bunge, Inhibits Doxorubicin-Induced Apoptosis by Inhibiting ROS and Activating JNK1/2 (Q57552177) (← links)
• Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin (Q64276382) (← links)
• Dexrazoxane treatment of doxorubicin extravasation injury in four dogs (Q83273758) (← links)
• Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity (Q89738089) (← links)
• Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper (Q89876415) (← links)
• Successful management of doxorubicin overdose and extravasation in a dog with lymphoma (Q90228595) (← links)
• DiOHF Protects Against Doxorubicin-Induced Cardiotoxicity Through ERK1 Signaling Pathway (Q90704695) (← links)